Slentz-Kesler K A, Hale L P, Kaufman R E
Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, 27710, USA.
Genomics. 1998 Feb 1;47(3):327-40. doi: 10.1006/geno.1997.5151.
The investigation of a DNase-hypersensitive site upstream of the CD7 gene on chromosome 17q25 has led to the discovery of a novel human gene designated K12 (SECTM1, the HGMW assignment). This gene spans approximately 14 kb and encodes a 1.8-kb mRNA detected at the highest levels in peripheral blood leukocytes and breast cancer cell lines. The open reading frame predicts a 248-amino-acid protein with the hydropathic characteristics of a type 1a membrane protein. Western blots show that the K12 protein exists as a cluster of bands around 27 kDa, and extractions using nonionic detergents or high pH conditions demonstrate that it behaves as an integral membrane protein. Immunofluorescence localization studies reveal that K12 is not detectable on the cell surface, but instead is found in a perinuclear Golgi-like pattern and colocalizes with a well-known Golgi marker. In addition, an approximately 20-kDa soluble form of the K12 protein derived from the N-terminal domain is specifically secreted by cells into the culture medium. Immunohistochemical analysis of peripheral blood cells shows that K12 is found in leukocytes of the myeloid lineage, with the strongest staining observed in granulocytes and no detectable expression in lymphocytes. Based on its range of expression, its broad structural characteristics that resemble cytokines and growth factors, and the chromosomal location of the gene in an area already associated with myelogenous leukemias and other malignant neoplasms, this study concludes that K12 is a novel molecule with potential importance in hematopoietic and/or immune system processes.
对位于17q25染色体上CD7基因上游的一个DNA酶高敏位点的研究,促成了一个名为K12(SECTM1,人类基因组命名委员会指定名称)的新型人类基因的发现。该基因跨度约14kb,编码一种1.8kb的mRNA,其在外周血白细胞和乳腺癌细胞系中的表达水平最高。开放阅读框预测该基因编码一个含有248个氨基酸的蛋白质,具有1a型膜蛋白的亲水性特征。蛋白质免疫印迹分析表明,K12蛋白以一组约27kDa的条带形式存在,使用非离子去污剂或高pH条件进行提取实验表明,它表现为一种整合膜蛋白。免疫荧光定位研究显示,在细胞表面未检测到K12蛋白,而是在核周高尔基体样模式中发现了它,并且它与一种知名的高尔基体标志物共定位。此外,一种源自N端结构域的约20kDa的K12蛋白可溶性形式被细胞特异性分泌到培养基中。对外周血细胞的免疫组织化学分析表明,K12蛋白存在于髓系谱系的白细胞中,在粒细胞中染色最强,在淋巴细胞中未检测到表达。基于其表达范围、类似于细胞因子和生长因子的广泛结构特征,以及该基因在一个已经与髓性白血病和其他恶性肿瘤相关的区域中的染色体定位,本研究得出结论,K12是一种在造血和/或免疫系统过程中可能具有重要意义的新型分子。